Literature DB >> 16262251

Expression of functional G protein-coupled receptors in photoreceptors of transgenic Xenopus laevis.

Li Zhang1, David Salom, Jianhua He, Alex Okun, Juan Ballesteros, Krzysztof Palczewski, Ning Li.   

Abstract

G protein-coupled receptors (GPCRs) constitute the largest superfamily of transmembrane signaling proteins; however, the only known GPCR crystal structure is that of rhodopsin. This disparity reflects the difficulty in generating purified GPCR samples of sufficient quantity and quality. Rhodopsin, the light receptor of retinal rod neurons, is produced in large amounts of homogeneous quality in the vertebrate retina. We used transgenic Xenopus laevis to convert these retina rod cells into bioreactors to successfully produce 20 model GPCRs. The receptors accumulated in rod outer segments and were homogeneously glycosylated. Ligand and [(35)S]GTPgammaS binding assays of the 5HT(1A) and EDG(1) GPCRs confirmed that they were properly folded and functional. 5HT(1A)R was highly purified by taking advantage of the rhodopsin C-terminal immunoaffinity tag common to all GPCR constructs. We have also developed an automated system that can generate hundreds of transgenic tadpoles per day. This expression approach could be extended to other animal model systems and become a general method for the production of large numbers of GPCRs and other membrane proteins for pharmacological and structural studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16262251     DOI: 10.1021/bi051386z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Post-translational modifications of the serotonin type 4 receptor heterologously expressed in mouse rod cells.

Authors:  David Salom; Benlian Wang; Zhiqian Dong; Wenyu Sun; Pius Padayatti; Steven Jordan; John A Salon; Krzysztof Palczewski
Journal:  Biochemistry       Date:  2011-12-20       Impact factor: 3.162

Review 2.  The significance of G protein-coupled receptor crystallography for drug discovery.

Authors:  John A Salon; David T Lodowski; Krzysztof Palczewski
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

Review 3.  Retinoids for treatment of retinal diseases.

Authors:  Krzysztof Palczewski
Journal:  Trends Pharmacol Sci       Date:  2010-06       Impact factor: 14.819

Review 4.  Membrane organization and function of the serotonin(1A) receptor.

Authors:  Shanti Kalipatnapu; Amitabha Chattopadhyay
Journal:  Cell Mol Neurobiol       Date:  2007-08-21       Impact factor: 5.046

5.  Adenovirus mediated expression "in vivo" of the chemokine receptor CXCR1.

Authors:  J Sarmiento; K E Kypreos; G N Prado; K Suetomi; C Stanzel; C Maxwell; D Shumate; M R Tandang-Silvas; K Rajarathnam; J Navarro
Journal:  J Struct Funct Genomics       Date:  2008-12-04

Review 6.  Rhodopsin: the functional significance of asn-linked glycosylation and other post-translational modifications.

Authors:  Anne R Murray; Steven J Fliesler; Muayyad R Al-Ubaidi
Journal:  Ophthalmic Genet       Date:  2009-09       Impact factor: 1.803

7.  Expression of mammalian G protein-coupled receptors in Caenorhabditis elegans.

Authors:  Beata Jastrzebska; David Salom; Hui Jin; Pengxiu Cao; Wenyu Sun; Krzysztof Palczewski; Zhaoyang Feng
Journal:  Methods Enzymol       Date:  2013       Impact factor: 1.600

Review 8.  From atomic structures to neuronal functions of g protein-coupled receptors.

Authors:  Krzysztof Palczewski; Tivadar Orban
Journal:  Annu Rev Neurosci       Date:  2013-05-15       Impact factor: 12.449

9.  Signals governing the trafficking and mistrafficking of a ciliary GPCR, rhodopsin.

Authors:  Kerrie H Lodowski; Richard Lee; Philip Ropelewski; Ina Nemet; Guilian Tian; Yoshikazu Imanishi
Journal:  J Neurosci       Date:  2013-08-21       Impact factor: 6.167

10.  All-trans-retinal induces Bax activation via DNA damage to mediate retinal cell apoptosis.

Authors:  Osamu Sawada; Lindsay Perusek; Hideo Kohno; Scott J Howell; Akiko Maeda; Shigemi Matsuyama; Tadao Maeda
Journal:  Exp Eye Res       Date:  2014-04-12       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.